Fluocinonide
Rank #473 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.3M
Total Cost
217,528
Total Claims
$15.3M
Total Cost
6,154
Prescribers
$70
Cost per Claim
101,106
Beneficiaries
232,877
30-Day Fills
$2,481
Avg Cost/Provider
35
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.3M total
Top Prescribers of Fluocinonide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Vlad Nusinovich | Internal Medicine | West Hollywood, CA | 428 | $452K |
| 2 | Louis Lam | Physician Assistant | New York, NY | 2,154 | $199K |
| 3 | Christopher Cepeda | Physician Assistant | Bronx, NY | 3,146 | $186K |
| 4 | Bernadette Guia | Nurse Practitioner | Panorama City, CA | 93 | $158K |
| 5 | Arkady Stern | Family Practice | Los Angeles, CA | 155 | $151K |
| 6 | Mikhail Chilingaryan | General Practice | Pittsburgh, PA | 161 | $144K |
| 7 | Ilya Rachman | Internal Medicine | Reseda, CA | 120 | $130K |
| 8 | Arutyun Topsakalyan | General Practice | Glendale, CA | 491 | $126K |
| 9 | Anahit Blikian | General Practice | Glendale, CA | 200 | $116K |
| 10 | Thomas Ratino | Interventional Pain Management | Fort Worth, TX | 455 | $115K |
| 11 | Tim Ratino | Interventional Pain Management | Fort Worth, TX | 418 | $105K |
| 12 | Armen Kazanchian | Internal Medicine | Glendale, CA | 60 | $101K |
| 13 | Mohammed Yousuf | Podiatry | Bronx, NY | 830 | $79K |
| 14 | Jimmy Van | Orthopaedic Surgery | Brooklyn, NY | 579 | $78K |
| 15 | Pinkas Lebovits | Dermatology | New York, NY | 909 | $78K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
| 471 | Avatrombopag Maleate (Doptelet) | $15.4M | 1,156 |
| 472 | Primidone (Primidone) | $15.3M | 450,535 |
| 473 | Fluocinonide (Fluocinonide) | $15.3M | 217,528 |
| 474 | Diclofenac Potassium (Diclofenac Potassium) | $15.2M | 96,736 |
| 475 | Capmatinib Hydrochloride (Tabrecta) | $15.1M | 824 |
| 476 | Berotralstat Hydrochloride (Orladeyo) | $15.1M | 374 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology